EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Capillarisin, a coumarin from Artemisia capillaris, alleviates APAP hepatotoxicity by targeting GSK3β/Nrf2 to suppress ferroptosis

Ludong Tan, Xiaodong Bai, Peiyuan Yu, Tinghan Jiang, Zhe Jin

Phytomedicine · 2026-09 · 159 · 158557

DOI: 10.1016/j.phymed.2026.158557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-09. Verfasst von Ludong Tan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, the First Hospital of Jilin University, Changchun, 130021, China. Hauptthemen laut MEDLINE: Artemisia, Acetaminophen, Ferroptosis, Coumarins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Acetaminophen (APAP) overdose is a leading cause of acute liver failure worldwide, characterized by oxidative stress-driven hepatocyte necrosis. Recent evidence implicates ferroptosis, an iron-dependent cell death, as a critical pathogenic event. Artemisia capillaris Thunb. (ACE) is a traditional hepatoprotective herb; however, its bioactive constituents and molecular targets regulating ferroptosis remain elusive. PURPOSE: This study aimed to identify the bioactive compounds of ACE and elucidate the molecular mechanism underlying its protective effect against APAP-induced hepatotoxicity, with a specific focus on the ferroptosis pathway. METHODS: We integrated multi-omics, network pharmacology, and rigorous biophysical assays to decipher the protective mechanism. The ethanol extract of A. capillaris was chemically characterized using UPLC-LTQ-Orbitrap MS. An APAP-induced acute liver injury model in C57BL/6 mice and primary mouse hepatocytes were employed. Transcriptomics (RNA-seq) was utilized to identify key signaling pathways. The direct physical interaction between the active compound and its target was validated using Microscale Thermophoresis (MST), Cellular Thermal Shift Assay (CETSA), Drug Affinity Responsive Target Stability (DARTS), and molecular dynamics (MD) simulations. Functional validation was performed using gene overexpression and specific inhibitors. RESULTS: ACE pretreatment significantly attenuated APAP-induced liver injury, inflammation, and oxidative stress in mice. Transcriptomic profiling identified ferroptosis as a primary target pathway. Through chemical screening, we identified Capillarisin as the key bioactive coumarin responsible for this effect. Capillarisin treatment effectively suppressed lipid peroxidation, iron overload, and the expression of ferroptotic markers (COX2, ACSL4) while restoring GPX4 levels both in vivo and in vitro. Mechanistically, we demonstrated that Capillarisin acts as a direct inhibitor of Glycogen Synthase Kinase 3β (GSK3β). Capillarisin binds stably to the ATP-binding pocket of GSK3β (Kd = 0.87 µM), thereby inhibiting its kinase activity. This inhibition blocks the phosphorylation-dependent degradation of Nrf2, promoting its nuclear translocation and the subsequent transcriptional activation of anti-ferroptotic genes (Gpx4, Slc7a11). Overexpression of GSK3β or pharmacological inhibition of Nrf2 abolished the protective effects of Capillarisin. CONCLUSION: Our study reveals a novel mechanism whereby Capillarisin alleviates APAP-induced hepatotoxicity by directly targeting GSK3β to activate the Nrf2-mediated anti-ferroptosis defense. These findings provide a rigorous scientific basis for the ethnopharmacological use of Artemisia capillaris and highlight Capillarisin as a promising lead candidate for targeting GSK3β in the treatment of drug-induced liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisiaAcetaminophenFerroptosisCoumarinsNF-E2-Related Factor 2Chemical and Drug Induced Liver InjuryGlycogen Synthase Kinase 3 betaAnimalsMiceMice, Inbred C57BLHepatocytesMaleSignal TransductionOxidative Stress

Stichwörter der Autor:innen

Artemisia capillarisCapillarisinDrug-induced liver injuryFerroptosisGSK3ΒNrf2

Substanzen

AcetaminophenCoumarinsNF-E2-Related Factor 2Glycogen Synthase Kinase 3 betaNfe2l2 protein, mouseGsk3b protein, mouse

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, the First Hospital of Jilin University, Changchun, 130021, China.
  • Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, the First Hospital of Jilin University, Changchun, 130021, China. Electronic address: jinxuanxu@jlu.edu.cn.

Zitieren

APA

Tan, L., Bai, X., Yu, P., Jiang, T., & Jin, Z. (2026). Capillarisin, a coumarin from Artemisia capillaris, alleviates APAP hepatotoxicity by targeting GSK3β/Nrf2 to suppress ferroptosis. Phytomedicine, 159, 158557. https://doi.org/10.1016/j.phymed.2026.158557

Vancouver

Tan L, Bai X, Yu P, Jiang T, Jin Z. Capillarisin, a coumarin from Artemisia capillaris, alleviates APAP hepatotoxicity by targeting GSK3β/Nrf2 to suppress ferroptosis. Phytomedicine. 2026;159:158557. doi:10.1016/j.phymed.2026.158557

BibTeX
@article{Tan2026,
  author = {Tan, Ludong and Bai, Xiaodong and Yu, Peiyuan and Jiang, Tinghan and Jin, Zhe},
  title = {Capillarisin, a coumarin from Artemisia capillaris, alleviates APAP hepatotoxicity by targeting GSK3β/Nrf2 to suppress ferroptosis},
  journal = {Phytomedicine},
  year = {2026},
  volume = {159},
  pages = {158557},
  doi = {10.1016/j.phymed.2026.158557}
}
Kostenlos starten →